We and others report AR SUMOylation regulates AR function as our collective whole animal and cell-based studies demonstrate that a disruption of dynamic AR SUMOylation directs aberrant proliferation of prostate and breast cancer cells (86–89). The gene discussed is AR; the disease is breast carcinoma.